The Comparison for this document will be available soon.
State
Facility type
County
The information provided is used to show regulations that are relevant to your region/facility. By using the platform you agree to the Terms and Conditions.
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
[customised-link]
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
The California Department of Public Health (CDPH) has issued an All Facilities Letter addressing the nationwide shortage of Tuberculin Skin Test Antigens. The letter provides guidance for healthcare facilities, including nursing homes, to request program flexibility for using alternate testing methods. CDPH has developed proposed regulations allowing the use of any test for tuberculin infection recommended by the CDC and licensed by the FDA. These regulations are currently under review by the Office of Administrative Law. In the meantime, healthcare facilities can use the attached template letter to request program flexibility from District Offices, which will expedite the process. The CDC recommends substituting the Interferon Gamma Release Assay (IGRA) blood tests to identify tuberculosis during the shortage. Facilities should contact their local District Office for further questions.
Summaries are generataed using AI. Check important information.